Sanofi showcases eczema data ahead of EU decision
September 19, 2017Dupixent predicted to be blockbuster for Sanofi
X
Sanofi showcases eczema data ahead of EU decision
https://pharmaphorum.com/news/dupixent-data-sanofi-ahead-eu-decision/
Sanofi
Novo highlights key ‘hypo’ data from Tresiba at EASD
September 15, 2017Novo hopes data will justify higher price compared with rival.
Alnylam halts trials of haemophilia drug after patient death
September 11, 2017Trials will resume once safety protocols have been reviewed.
NICE wants to axe funding for two thyroid cancer drugs
August 23, 2017NICE unconvinced by survival data from Ipsen and Sanofi drugs
Novo Nordisk may drop US insulin price as Sanofi suffers
August 9, 2017Biosimilar Lantus is causing rivals to cut prices to compete
Ablynx and Sanofi sign potential 2.4bn euro R&D deal
July 20, 2017Collaboration will develop drugs for inflammatory diseases
Amicus to file Fabry drug after FDA changes mind
July 12, 2017Regulator drops demand for further phase 3 trial.
Sanofi $750m acquisition gives it edge in flu vacccine market
July 11, 2017Biotech’s Flublok is only FDA-approved cell-based flu jab
NICE recommends Sanofi’s Gaucher treatment
June 28, 2017Cancer drugs from Novartis and Pfizer also backed
